Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

2.03
Delayed Data
As of Dec 09
 +0.03 / +1.50%
Today’s Change
0.67
Today|||52-Week Range
2.10
+67.77%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$314.8M

Company Description

Antares Pharma, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It has one operating segment, drug delivery, which includes the development of injection devices and injection based pharmaceutical products as well as transdermal gel products. The company was founded in 1979 and is headquartered in Ewing, NJ.

Contact Information

Antares Pharma, Inc.
100 Princeton South
Ewing New Jersey 08628
P:(609) 359-3020
Investor Relations:
(609) 359-3016

Employees

Shareholders

Mutual fund holders7.00%
Other institutional25.88%
Individual stakeholders20.88%

Top Executives

Robert F. ApplePresident, Chief Executive Officer & Director
Fred M. PowellChief Financial Officer & Senior Vice President
Peter L. SadowskiSenior Vice President-Technology
Jonathan S. JaffeVice President-Clinical & Medical Affairs
Peter J. GrahamSecretary, Chief Compliance Officer & Senior VP